Recent developments have underlined both the momentum and the complexity of the AOM landscape
Abbreviations CMAP: Compound motor action potential CNS: Central nervous system ECM: Cone-extracellular matrix egr-1 gene : Early growth response-1 gene EMG: Electromyography FAK: Focal adhesion kinase GLP: Good laboratory practice HNE: 4-Hydroxynonenal HPLC: High-pressure liquid chromatography JAK-2: Janus kinase 2 LD1: Lethal dose 1 LTB4: Leukotriene B4 MPO: Myeloperoxidase MPTP: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine MUP: Motor unit potential naB2: Nerve growth factor 1-A binding protein-2 NSAIDs: Non-steroid anti-inflammatory drugs SCI: Spinal cord injury TXB2: Thromboxane B2 References Seiwerth S, Rucman R, Turkovic B, Sever M, Klicek R, Radic B, et al
Journal of the International Society of Sports Nutrition, 17(1)
The other half used a placebo
Sci Rep 6 , 29743 (2016)
The Reduction of Cardiovascular Events with Icosapent EthylIntervention Trial (REDUCE-IT) evaluated the impact of treating patients with established ASCVD and high risk diabetic patients already on a statin with 4.0 g of highly purified EPA (icosapent ethyl) daily [79]
